Liver Cancer Clinical Trials in Long Beach, CA

62 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	Phase 3	Children's Oncology Group	<1 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI	N/A	VA Office of Research and Development	<1 mi
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment	Phase 1	Gilead Sciences	<1 mi
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma	Phase 2	Coherus Oncology, Inc.	7 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors	Phase 2	SWOG Cancer Research Network	10 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis	Phase 2	Genentech, Inc.	10 mi
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer	Phase 1	TORL Biotherapeutics, LLC	10 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	10 mi
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment	—	Fresenius Kabi	14 mi
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)	—	HistoSonics, Inc.	17 mi
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)	Phase 2	Daiichi Sankyo	17 mi
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer	Phase 2	AstraZeneca	18 mi
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)	Phase 1/2	Hoffmann-La Roche	18 mi
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies	Phase 1	SEED Therapeutics, Inc.	19 mi
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen	Phase 3	Crinetics Pharmaceuticals Inc.	19 mi
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)	Phase 1	AbbVie	20 mi
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors	Phase 1	Seagen, a wholly owned subsidiary of Pfizer	20 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	20 mi
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial	Phase 1/2	National Cancer Institute (NCI)	20 mi
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resectable Liver Cancer Before Surgery	Phase 2	National Cancer Institute (NCI)	20 mi
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial	Phase 3	NRG Oncology	20 mi
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)	Phase 2/3	AbbVie	20 mi
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)	N/A	ABK Biomedical	20 mi
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma	Phase 1/2	Tvardi Therapeutics, Incorporated	20 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors	Phase 1/2	Children's Oncology Group	20 mi
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers	N/A	University of California, Irvine	20 mi
Combination of TATE and PD-1 Inhibitor in Liver Cancer	Phase 2	Teclison Ltd.	20 mi
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial	Phase 2	University of California, Irvine	20 mi
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma	Phase 2	University of California, Irvine	20 mi
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC	Phase 2	Teclison Ltd.	20 mi
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor	Phase 1/2	Eisai Inc.	20 mi
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	20 mi
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors	Phase 1/2	Qurient Co., Ltd.	20 mi
National Liver Cancer Screening Trial	Phase 4	University of Texas Southwestern Medical Center	20 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma	Phase 1	Alnylam Pharmaceuticals	20 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations	Phase 1	Tyra Biosciences, Inc	20 mi
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors	Phase 1	Angiex, Inc.	20 mi
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease	Phase 1	University of Southern California	20 mi
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors	Phase 2	DualityBio Inc.	20 mi
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma	Phase 1	Nammi Therapeutics Inc	20 mi
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers	Phase 1	Jonsson Comprehensive Cancer Center	20 mi
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A	Cedars-Sinai Medical Center	20 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	20 mi
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases	Phase 2	Kamya Sankar	20 mi
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer	Phase 2	AstraZeneca	20 mi
Observational Study Protocol: LIVER-R	—	AstraZeneca	20 mi
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours	Phase 1/2	AstraZeneca	20 mi
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots	—	University of Southern California	20 mi
A Study of MGC026 in Participants With Advanced Solid Tumors	Phase 1	MacroGenics	20 mi
SIRT With Tremelimumab and Durvalumab for Resectable HCC	Phase 1	Jiping Wang, MD, PhD	20 mi
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC	Phase 2	Replimune Inc.	24 mi
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease	Phase 2	Delcath Systems Inc.	24 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma	Phase 3	AstraZeneca	24 mi
A Cell-free tsRNA Signature for Early Detection of Hepatocellular Carcinoma	—	City of Hope Medical Center	28 mi
An Exosomal miRNA-based Liquid Biopsy for ICC Detection	—	City of Hope Medical Center	28 mi
Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases	—	City of Hope Medical Center	28 mi
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer	—	City of Hope Medical Center	28 mi
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer	Phase 2	City of Hope Medical Center	28 mi
T-Cell Therapy (ECT204) in Adults With Advanced HCC	Phase 1/2	Eureka Therapeutics Inc.	28 mi
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer	—	City of Hope Medical Center	28 mi
Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.	—	City of Hope Medical Center	28 mi
Early Detection of Advanced Adenomas and Colorectal Cancer	—	City of Hope Medical Center	28 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.